Methane limit LPS-induced NF-κ B/MAPKs signal in macrophages and suppress immune response in mice by enhancing PI3K/AKT/GSK-3β-mediated IL-10 expression

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zhang, Xu ^a,b,c   Li, Na ^a   Shao, Han ^a,b,c   Meng, Yan ^a   Wang, Liping ^a,d   Wu, Qian ^a   Yao, Ying ^a   Li, Jinbao ^a   Bian, Jinjun ^a   Zhang, Yan ^a   Deng, Xiaoming ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b XUZHOU MEDICAL UNIVERSITY   (China)

^c Jiangsu Province Key Laboratory of Anesthesia and Analgesia Application Technology   (China)

^d Tuberculosis Department   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; LIPOPOLYSACCHARIDE; METHANE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TLR4 PROTEIN, MOUSE; TOLL LIKE RECEPTOR 4;

ANIMAL; C57BL MOUSE; DRUG EFFECT; IMMUNE SYSTEM; METABOLISM; MOUSE; PERITONEUM MACROPHAGE; SIGNAL TRANSDUCTION;

ANIMALS; GLYCOGEN SYNTHASE KINASE 3 BETA; IMMUNE SYSTEM; INTERLEUKIN-10; LIPOPOLYSACCHARIDES; MACROPHAGES, PERITONEAL; METHANE; MICE; MICE, INBRED C57BL; MITOGEN-ACTIVATED PROTEIN KINASES; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84978372571     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep29359     Document Type: Article

References (50)

1. Poltorak, A. et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282, 2085-2088 (1998).
2. O'Neill, L. A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunological reviews 226, 10-18, doi: 10.1111/j.1600-065X.2008.00701.x (2008).
3. Kawai, T., Akira, S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nature immunology 11, 373-384, doi: 10.1038/ni.1863 (2010).
4. Hamerman, J. A. et al. Negative regulation of TLR signaling in myeloid cells-implications for autoimmune diseases. Immunological reviews 269, 212-227, doi: 10.1111/imr.12381 (2016).
5. Marshak-Rothstein, A., Rifkin, I. R. Immunologically active autoantigens: the role of toll-like receptors in the development of chronic inflammatory disease. Annual review of immunology 25, 419-441, doi: 10.1146/annurev.immunol.22.012703.104514 (2007).
6. Cho, J. H., Feldman, M. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies. Nature medicine 21, 730-738, doi: 10.1038/nm.3897 (2015).
7. Choy, E. H., Kavanaugh, A. F., Jones, S. A. The problem of choice: current biologic agents and future prospects in RA. Nature reviews. Rheumatology 9, 154-163, doi: 10.1038/nrrheum.2013.8 (2013).
8. Hutchins, A. P., Diez, D., Miranda-Saavedra, D. The IL-10/STAT3-mediated anti-inflammatory response: recent developments and future challenges. Briefings in functional genomics 12, 489-498, doi: 10.1093/bfgp/elt028 (2013).
9. Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., Hymowitz, S. G. Regulation and functions of the IL-10 family of cytokines in inflammation and disease. Annual review of immunology 29, 71-109, doi: 10.1146/annurev-immunol-031210-101312 (2011).
10. Yao, Y., Simard, A. R., Shi, F. D., Hao, J. IL-10-producing lymphocytes in inflammatory disease. International reviews of immunology 32, 324-336, doi: 10.3109/08830185.2012.762361 (2013).
11. Pimentel, M. et al. Methane, a gas produced by enteric bacteria, slows intestinal transit and augments small intestinal contractile activity. American journal of physiology. Gastrointestinal and liver physiology 290, G1089-1095, doi: 10.1152/ajpgi.00574.2004 (2006).
12. Ghyczy, M. et al. Hypoxia-induced generation of methane in mitochondria and eukaryotic cells: an alternative approach to methanogenesis. Cellular physiology and biochemistry: international journal of experimental cellular physiology, biochemistry, and pharmacology 21, 251-258, doi: 10.1159/000113766 (2008).
13. Ghyczy, M., Torday, C., Boros, M. Simultaneous generation of methane, carbon dioxide, and carbon monoxide from choline and ascorbic acid: a defensive mechanism against reductive stress? FASEB journal: official publication of the Federation of American Societies for Experimental Biology 17, 1124-1126, doi: 10.1096/fj.02-0918fje (2003).
14. Roccarina, D. et al. The role of methane in intestinal diseases. The American journal of gastroenterology 105, 1250-1256, doi: 10.1038/ajg.2009.744 (2010).
15. Yang, Y. X., Mu, C. L., Luo, Z., Zhu, W. Y. Bromochloromethane, a methane analogue, affects the gut microbiota and metabolic profiles of the rat gastrointestinal tract. Applied and environmental microbiology, doi: 10.1128/AEM.03174-15 (2015).
16. Sahakian, A. B., Jee, S. R., Pimentel, M. Methane and the gastrointestinal tract. Digestive diseases and sciences 55, 2135-2143, doi: 10.1007/s10620-009-1012-0 (2010).
17. Jahng, J., Jung, I. S., Choi, E. J., Conklin, J. L., Park, H. The effects of methane and hydrogen gases produced by enteric bacteria on ileal motility and colonic transit time. Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society 24, 185-190, e192, doi: 10.1111/j.1365-2982.2011.01819.x (2012).
18. Boros, M. et al. The anti-inflammatory effects of methane. Crit Care Med 40, 1269-1278, doi: 10.1097/CCM.0b013e31823dae05 (2012).
19. Chen, O. et al. Methane attenuates myocardial ischemia injury in rats through anti-oxidative, anti-apoptotic and anti-inflammatory actions. Free radical biology & medicine 90, 1-11, doi: 10.1016/j.freeradbiomed.2015.11.017 (2015).
20. Ye, Z. et al. Methane Attenuates Hepatic Ischemia/Reperfusion Injury in Rats Through Antiapoptotic, Anti-Inflammatory, and Antioxidative Actions. Shock 44, 181-187, doi: 10.1097/SHK.0000000000000385 (2015).
21. Song, K. et al. Methane-rich saline attenuates ischemia/reperfusion injury of abdominal skin flaps in rats via regulating apoptosis level. BMC surgery 15, 92, doi: 10.1186/s12893-015-0075-4 (2015).
22. Wu, J. et al. Protective effects of methane-rich saline on diabetic retinopathy via anti-inflammation in a streptozotocin-induced diabetic rat model. Biochemical and biophysical research communications 466, 155-161, doi: 10.1016/j.bbrc.2015.08.121 (2015).
23. Haziot, A., Hijiya, N., Gangloff, S. C., Silver, J., Goyert, S. M. Induction of a novel mechanism of accelerated bacterial clearance by lipopolysaccharide in CD14-deficient and Toll-like receptor 4-deficient mice. Journal of immunology 166, 1075-1078 (2001).
24. Mittal, S. K., Roche, P. A. Suppression of antigen presentation by IL-10. Current opinion in immunology 34, 22-27, doi: 10.1016/j. coi.2014.12.009 (2015).
25. Elcombe, S. E. et al. Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers. PloS one 8, e60086, doi: 10.1371/journal.pone.0060086 (2013).
26. Ananieva, O. et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nature immunology 9, 1028-1036, doi: 10.1038/ni.1644 (2008).
27. Beurel, E., Michalek, S. M., Jope, R. S. Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3). Trends in immunology 31, 24-31, doi: 10.1016/j.it.2009.09.007 (2010).
28. Beurel, E., Grieco, S. F., Jope, R. S. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases. Pharmacology & therapeutics 148, 114-131, doi: 10.1016/j.pharmthera.2014.11.016 (2015).
29. Rehani, K. et al. Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells. Biochimica et biophysica acta 1783, 375-382, doi: 10.1016/j.bbamcr.2007.12.003 (2008).
30. Gabrysova, L., Howes, A., Saraiva, M., O'Garra, A. The regulation of IL-10 expression. Current topics in microbiology and immunology 380, 157-190, doi: 10.1007/978-3-662-43492-5-8 (2014).
31. Cao, S., Zhang, X., Edwards, J. P., Mosser, D. M. NF-kappaB1 (p50) homodimers differentially regulate pro-and anti-inflammatory cytokines in macrophages. The Journal of biological chemistry 281, 26041-26050, doi: 10.1074/jbc.M602222200 (2006).
32. Nandan, D. et al. Myeloid cell IL-10 production in response to leishmania involves inactivation of glycogen synthase kinase-3beta downstream of phosphatidylinositol-3 kinase. Journal of immunology 188, 367-378, doi: 10.4049/jimmunol.1100076 (2012).
33. MacKenzie, K. F. et al. PGE(2) induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIKCRTC3 pathway. Journal of immunology 190, 565-577, doi: 10.4049/jimmunol.1202462 (2013).
34. Sanin, D. E., Prendergast, C. T., Mountford, A. P. IL-10 Production in Macrophages Is Regulated by a TLR-Driven CREB-Mediated Mechanism That Is Linked to Genes Involved in Cell Metabolism. Journal of immunology 195, 1218-1232, doi: 10.4049/jimmunol.1500146 (2015).
35. Chen, G. et al. Cyanidin-3-glucoside reverses ethanol-induced inhibition of neurite outgrowth: role of glycogen synthase kinase 3 Beta. Neurotoxicity research 15, 321-331, doi: 10.1007/s12640-009-9036-y (2009).
36. Martin, M., Rehani, K., Jope, R. S., Michalek, S. M. Toll-like receptor-mediated cytokine production is differentially regulated by glycogen synthase kinase 3. Nature immunology 6, 777-784, doi: 10.1038/ni1221 (2005).
37. Hu, X. et al. IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB/AP-1 proteins. Immunity 24, 563-574, doi: 10.1016/j.immuni.2006.02.014 (2006).
38. Ohtani, M. et al. Mammalian target of rapamycin and glycogen synthase kinase 3 differentially regulate lipopolysaccharide-induced interleukin-12 production in dendritic cells. Blood 112, 635-643, doi: 10.1182/blood-2008-02-137430 (2008).
39. Fan, W. et al. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. The EMBO journal 29, 4223-4236, doi: 10.1038/emboj.2010.268 (2010).
40. Brown, J., Wang, H., Suttles, J., Graves, D. T., Martin, M. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. The Journal of biological chemistry 286, 44295-44305, doi: 10.1074/jbc.M111.258053 (2011).
41. Kai, T., Jones, K. A., Warner, D. O. Halothane attenuates calcium sensitization in airway smooth muscle by inhibiting G-proteins. Anesthesiology 89, 1543-1552 (1998).
42. Sokoll, M. D., Davies, L. R., Bhattacharyya, B., Zwagerman, D. Q. Halothane and isoflurane alter acetylcholine activated ion channel kinetics. European journal of pharmacology 173, 27-34 (1989).
43. Puig, M. M., Warner, W., Tang, C. K., Lovitz, M., Turndorf, H. Synergistic interaction of morphine and halothane in the guinea pig ileum. Anesthesiology 68, 559-562 (1988).
44. Venardos, K. M., Perkins, A., Headrick, J., Kaye, D. M. Myocardial ischemia-reperfusion injury, antioxidant enzyme systems, and selenium: a review. Current medicinal chemistry 14, 1539-1549 (2007).
45. Viatour, P. et al. GSK3-mediated BCL-3 phosphorylation modulates its degradation and its oncogenicity. Molecular cell 16, 35-45, doi: 10.1016/j.molcel.2004.09.004 (2004).
46. Schwabe, R. F., Brenner, D. A. Role of glycogen synthase kinase-3 in TNF-alpha-induced NF-kappaB activation and apoptosis in hepatocytes. American journal of physiology. Gastrointestinal and liver physiology 283, G204-211, doi: 10.1152/ajpgi.00016.2002 (2002).
47. Hill, E. V. et al. Glycogen synthase kinase-3 controls IL-10 expression in CD4(+ ) effector T-cell subsets through epigenetic modification of the IL-10 promoter. European journal of immunology 45, 1103-1115, doi: 10.1002/eji.201444661 (2015).
48. Ying, W., Cheruku, P. S., Bazer, F. W., Safe, S. H., Zhou, B. Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages. e50323, doi: 10.3791/50323 (2013).
49. Ohsawa, I. et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nature medicine 13, 688-694, doi: 10.1038/nm1577 (2007).
50. Zanotti-Cavazzoni, S. L. et al. Fluid resuscitation influences cardiovascular performance and mortality in a murine model of sepsis. Intensive care medicine 35, 748-754, doi: 10.1007/s00134-008-1360-9 (2009).